Clinical Trial Update: CD4^LVFOXP3 in Participants With IPEX [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating CD4LVFOXP3 therapy in participants with IPEX syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ipex Syndrome

Drugs mentioned

• CD4LVFOXP3

Snippet

Sponsor: Bacchetta, Rosa, MD | Conditions: IPEX | Phase 1 | Status: RECRUITING